Predicting Treatment Failure for Initiators of Hepatitis C Virus Treatment in the era of Direct-Acting Antiviral Therapy
Introduction: Hepatitis C virus (HCV), the leading cause of advanced liver disease, has enormous economic burden. Identification of patients at risk of treatment failure could lead to interventions that improve cure rates.Objectives: Our goal was to develop and evaluate a prediction model for HCV tr...
Main Authors: | Nadia A. Nabulsi, Michelle T. Martin, Lisa K. Sharp, David E. Koren, Robyn Teply, Autumn Zuckerman, Todd A. Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.551500/full |
Similar Items
-
Concordance of sustained virologic response at weeks 4, 12 and 24 post-treatment of hepatitis C in the era of new oral direct-acting antivirals: A concise review
by: Sarah V. Burgess, et al.
Published: (2016-03-01) -
A nurse practitioner model of care in the era of direct acting antiviral therapy for hepatitis C virus infection
by: Steffanie Nario, et al.
Published: (2021-06-01) -
Hepatitis C direct‐acting antiviral outcomes in patients 75 years and older
by: Parmvir Parmar, et al.
Published: (2021-02-01) -
New treatment of hepatitis C (Direct Acting Antiviral)
by: Mohsen Akhondi-Meybodi
Published: (2019-10-01) -
Effectiveness of Direct-Acting Antivirals in Treatment of Elderly Egyptian Chronic Hepatitis C Patients
by: Shimaa Kamel, et al.
Published: (2021-07-01)